Oncology & Cancer

Interleukin-6 may boost prediction of obesity-related cancers

In patients with newly diagnosed type 2 diabetes, baseline interleukin-6 (IL-6) levels may enhance prediction of new-onset obesity-related cancers, according to a study scheduled to be presented at the annual meeting of the ...

page 11 from 40